SME Times is powered by   
Search News
Just in:   • Adani Group to invest Rs 57,575 crore in Odisha  • 'Dollar Distancing' finally happening? Time for India to pitch Rupee as credible alternative: SBI Ecowrap  • 49% Indian startups now from tier 2, 3 cities: Jitendra Singh  • 'India ranks 3rd in global startup ecosystem & number of unicorns'  • LinkedIn lays off entire global events marketing team: Report 
Last updated: 13 Feb, 2018  

Fortis.jpg 'Management Committee' to oversee Fortis Healthcare, results on Feb 28

Fortis.9.jpg
   Top Stories
» 49% Indian startups now from tier 2, 3 cities: Jitendra Singh
» 'India ranks 3rd in global startup ecosystem & number of unicorns'
» Tripura exported over 9K tonnes of pineapples in 2 years
» CPI inflation eases to 6.71% in July, IIP falls to 12.3%
» Rupee depreciates 12 paise to close at 79.64 against US dollar
SME Times News Bureau | 13 Feb, 2018
Fortis Healthcare on Tuesday said that it has accepted the resignations of its promoters and as an interim measure constituted a "Management Committee" to oversee its functioning.

According to a BSE filing, the company's Board of Directors "today accepted the resignations of Mr Malvinder Mohan Singh, Executive Chairman and Dr Shivinder Mohan Singh Non-Executive Vice Chairman with effect from February 8, 2018".

"The board acknowledged and placed on record their support and contribution in making Fortis a par excellence healthcare delivery service provider," the BSE filing said.

"The board, as an interim measure, has constituted a management committee to oversee the functioning of the company from a strategic and operational guidance perspective and vested with the management committee all the responsibilities and authorities of executive chairman and non-executive vice chairman."

On February 9, the promoters of Fortis Healthcare had resigned from the company's board days after the Delhi High Court upheld an international arbitral award of Rs 3,500 crore to Daiichi Sankyo against the former promoters of Ranbaxy Laboratories.

Further on Tuesday, the company said that it will come out with the un-audited financial results for the quarters ended September 30, 2017 and December 31, 2017 on February 28, 2018.

It had earlier requested the stock exchanges for extending the timelines for holding board meeting for approval of the results which could not be tabled on Tuesday during its board meeting and "... therefore the results were not considered and approved".

"The board decided to hold the board meeting for approval of the financial results for the quarters ended September 30, 2017 and December 31, 2017 on February 28, 2018.
Accordingly, the trading window will continue to remain Closed till March 2, 2018," the filing said.

 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
66.20
64.50
UK Pound
87.50
84.65
Euro
78.25
75.65
Japanese Yen 58.85 56.85
As on 13 Aug, 2022
  Daily Poll
PM Modi's recent US visit to redefine India-US bilateral relations
 Yes
 No
 Can't say
  Commented Stories
» GIC Re's revenue from obligatory cession threatened(1)
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter